Preliminary estimation of treatment effect on uterine cervical squamous cell carcinoma in terms of tumor regression rate: Comparison between chemoradiotherapy and radiotherapy alone

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 23, Issue 1, 2005, Pages 25-29

  Ohara, Kiyoshi ^a,b   Tanaka, Yumiko Oishi ^a   Tsunoda, Hajime ^a   Oki, Akinori ^a   Satoh, Toyomi ^a   Onishi, Kayoko ^a   Kagei, Kenji ^a   Sugahara, Shinji ^a   Hata, Masaharu ^a   Igaki, Hiroshi ^a   Tokuuye, Koichi ^a   Akine, Yasuyuki ^a   Yoshikawa, Hiroyuki ^a  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Minimum target dose; Radiosensitivity; Response rate

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM TARGET DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 20144374276     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. National Cancer Institute. Cervical Cancer (PDQ): Treatment. Available at http://www.cancer.gov/ cancerinfo/pdq/treatment/cervical/healthprofessional/. Accessed March 2004.
2. Togashi K, Morikawa K, Kataoka ML, Konishi J. Cervical cancer. J Magn Reson Imaging, 8: 391-397, 1998.
3. Gong QY, Tan LT, Romaniuk CS, Jones B, Brunt JNH, Roberts N. Determination of tumor regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variability. Br J Radiol, 72: 62-72, 1999.
4. Ohara K, Tanaka YO, Sugahara S, Itai Y. Preliminary estimation of minimum target dose in intracavitary radiotherapy for cervical cancer. Radiat Med, 19: 193-196, 2001.
5. Kim RY, Spencer SA. Tumor shrinkage before intracavitary brachytherapy for cancer of the cervix: radiotherapy alone versus concurrent chemoradiotherapy. Cancer J, 6: 377-380, 2000.
6. Kodaira T, Fuwa N, Kamata M, et al. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with stage II disease suitable candidates for chemoradiotherapy? Int J Radiat Oncol Biol Phys, 52: 627-636, 2002.
7. Rose PG. Chemoradiotherapy for cervical cancer. Eur J Cancer, 38: 270-278, 2002.